CN Stock MarketDetailed Quotes

603896 Zhejiang Shouxiangu Pharmaceutical

Watchlist
  • 19.80
  • +0.01+0.05%
Market Closed Sep 11 15:00 CST
3.93BMarket Cap14.81P/E (TTM)

Zhejiang Shouxiangu Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-5.09%352.59M
7.15%220.9M
-5.39%784.35M
6.89%542.63M
6.28%371.49M
1.20%206.16M
8.07%829.07M
5.82%507.64M
10.09%349.53M
16.99%203.72M
Operating revenue
-5.09%352.59M
7.15%220.9M
-5.39%784.35M
6.89%542.63M
6.28%371.49M
1.20%206.16M
8.07%829.07M
5.82%507.64M
10.09%349.53M
16.99%203.72M
Other operating revenue
-8.68%6.13M
----
22.89%14.01M
----
43.59%6.72M
----
59.49%11.4M
----
47.25%4.68M
----
Total operating cost
-7.57%275.47M
1.23%153.63M
-0.43%574.86M
6.79%427.39M
3.99%298.02M
1.09%151.77M
1.56%577.34M
-1.03%400.22M
4.55%286.59M
8.57%150.14M
Operating cost
-1.14%65.94M
11.17%37.74M
4.89%135.53M
23.61%94.46M
27.10%66.7M
14.69%33.95M
2.24%129.21M
-7.96%76.42M
-4.69%52.48M
5.25%29.6M
Operating tax surcharges
23.33%4.31M
53.66%3.16M
24.03%8.91M
13.67%5.2M
-1.67%3.5M
23.52%2.06M
-8.06%7.18M
-20.74%4.57M
-15.10%3.56M
-23.58%1.66M
Operating expense
-5.44%156.09M
2.40%90.88M
-0.81%316.79M
-2.46%230.67M
-4.29%165.07M
-6.76%88.75M
-0.12%319.37M
-0.30%236.48M
8.16%172.47M
14.85%95.19M
Administration expense
-1.03%41.78M
5.10%21.06M
1.39%86.99M
18.60%68.02M
18.21%42.21M
14.36%20.04M
10.81%85.8M
1.99%57.36M
-1.73%35.71M
-6.42%17.52M
Financial expense
-163.13%-15.81M
-138.66%-10.64M
-91.24%-23.04M
13.90%-10.81M
-31.83%-6.01M
4.18%-4.46M
12.13%-12.05M
2.98%-12.55M
-73.41%-4.56M
-116.52%-4.65M
-Interest expense (Financial expense)
-57.50%7.94M
-50.28%4.69M
89.62%24.7M
262.17%26.18M
377.57%18.67M
398.90%9.44M
28.10%13.03M
-13.37%7.23M
-38.24%3.91M
-46.07%1.89M
-Interest Income (Financial expense)
3.73%-23.91M
-27.75%-17.89M
-88.97%-48.09M
-85.49%-37.23M
-188.05%-24.83M
-111.06%-14M
-5.31%-25.45M
6.64%-20.07M
5.33%-8.62M
-15.45%-6.63M
Research and development
-12.79%23.17M
-0.03%11.43M
3.89%49.68M
5.03%39.85M
-1.38%26.56M
5.67%11.43M
-5.90%47.82M
8.08%37.94M
24.16%26.93M
26.77%10.82M
Credit Impairment Loss
-137.20%-509.76K
-343.48%-3.12M
159.92%1.13M
-46.23%576.16K
3.15%1.37M
576.52%1.28M
-78.54%-1.88M
98.71%1.07M
7.19%1.33M
-340.71%-268.52K
Adjustment items of total operating cost
----
---0.01
----
----
----
----
----
----
----
----
Other net revenue
59.02%23.49M
56.73%9.42M
55.22%45.24M
-6.63%22.65M
-25.88%14.77M
6.78%6.01M
242.75%29.15M
59.02%24.26M
53.15%19.93M
2.29%5.63M
Fair value change income
----
----
121.54%271.43K
121.54%271.43K
121.54%271.43K
----
89.78%-1.26M
---1.26M
---1.26M
----
Invest income
-26.67%2.47M
-84.91%90.9K
-18.92%3.68M
-10.44%3.42M
-5.56%3.37M
-33.29%602.25K
-33.58%4.54M
-10.56%3.82M
-11.21%3.57M
234.50%902.85K
-Including: Investment income associates
-311.60%-130.43K
164.42%90.9K
245.95%375.71K
142.43%117.75K
131.56%61.64K
-227.55%-141.09K
74.62%-257.43K
54.73%-277.49K
50.12%-195.31K
139.11%110.62K
Asset deal income
726,271.92%8.6M
--5.68M
138.26%172.51K
-108.95%-1.18K
-108.95%-1.18K
----
110.36%72.4K
-62.70%13.23K
-64.86%13.23K
--13.23K
Other revenue
32.44%12.93M
63.95%6.77M
44.49%39.99M
-10.83%18.38M
-40.03%9.77M
-17.11%4.13M
84.30%27.67M
98.06%20.61M
110.88%16.29M
-2.73%4.98M
Operating profit
14.01%100.61M
26.98%76.7M
-9.31%254.72M
4.71%137.9M
6.48%88.24M
2.01%60.4M
35.59%280.88M
45.34%131.69M
46.95%82.87M
43.20%59.21M
Add:Non operating Income
-85.59%360.85K
-90.14%244.42K
507.13%2.6M
573.27%2.52M
6,858.44%2.5M
20,937.07%2.48M
225.29%428.21K
284.92%374.15K
-54.49%35.98K
-57.48%11.79K
Less:Non operating expense
-66.78%130.22K
-63.74%67.25K
-27.83%2.41M
-48.06%744.62K
88.00%391.96K
503.22%185.45K
-46.32%3.34M
-56.00%1.43M
-88.84%208.49K
-85.01%30.74K
Total profit
11.60%100.84M
22.61%76.87M
-8.29%254.91M
6.92%139.67M
9.25%90.35M
5.92%62.7M
38.25%277.97M
49.38%130.63M
51.44%82.7M
43.77%59.19M
Less:Income tax cost
-131.47%-37.06K
-402.30%-256.56K
-4.79%430.87K
-36.78%308.73K
-77.44%117.76K
65.55%84.87K
-39.60%452.57K
-37.52%488.31K
234.94%521.98K
183.06%51.26K
Net profit
11.79%100.87M
23.19%77.13M
-8.30%254.48M
7.09%139.36M
9.80%90.24M
5.86%62.61M
38.54%277.51M
50.16%130.14M
49.43%82.18M
43.43%59.14M
Net profit from continuing operation
11.79%100.87M
23.19%77.13M
-8.30%254.48M
7.09%139.36M
9.80%90.24M
5.86%62.61M
38.54%277.51M
50.16%130.14M
49.43%82.18M
43.43%59.14M
Less:Minority Profit
----
----
----
----
----
----
47.58%-270.07K
100.98%3.78K
--162.71K
--148.14K
Net profit of parent company owners
11.79%100.87M
23.19%77.13M
-8.39%254.48M
7.09%139.36M
10.02%90.24M
6.13%62.61M
38.32%277.78M
49.49%130.14M
49.13%82.02M
43.07%58.99M
Earning per share
Basic earning per share
10.87%0.51
21.88%0.39
-9.09%1.3
5.97%0.71
9.52%0.46
6.67%0.32
36.19%1.43
48.89%0.67
44.83%0.42
7.14%0.3
Diluted earning per share
10.87%0.51
21.88%0.39
-9.09%1.3
5.97%0.71
9.52%0.46
6.67%0.32
36.19%1.43
48.89%0.67
44.83%0.42
7.14%0.3
Other composite income
133.22%12.9M
87.02%10.7M
247.16%2.99M
270.86%5.39M
19.38%5.53M
17.39%5.72M
-4.33%-2.03M
-1,720.91%-3.15M
42.31%4.63M
-45.39%4.88M
Other composite income of parent company owners
133.22%12.9M
87.02%10.7M
247.16%2.99M
270.86%5.39M
19.38%5.53M
17.39%5.72M
-4.33%-2.03M
-1,720.91%-3.15M
42.31%4.63M
-45.39%4.88M
Total composite income
18.80%113.78M
28.54%87.83M
-6.54%257.47M
13.99%144.75M
10.32%95.77M
6.74%68.33M
38.88%275.48M
46.19%126.99M
49.03%86.81M
27.62%64.02M
Total composite income of parent company owners
18.80%113.78M
28.54%87.83M
-6.63%257.47M
13.99%144.75M
10.52%95.77M
6.99%68.33M
38.65%275.75M
45.54%126.98M
48.75%86.65M
27.33%63.87M
Total composite income of minority owners
----
----
----
----
----
----
47.58%-270.07K
100.98%3.78K
--162.71K
--148.14K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -5.09%352.59M7.15%220.9M-5.39%784.35M6.89%542.63M6.28%371.49M1.20%206.16M8.07%829.07M5.82%507.64M10.09%349.53M16.99%203.72M
Operating revenue -5.09%352.59M7.15%220.9M-5.39%784.35M6.89%542.63M6.28%371.49M1.20%206.16M8.07%829.07M5.82%507.64M10.09%349.53M16.99%203.72M
Other operating revenue -8.68%6.13M----22.89%14.01M----43.59%6.72M----59.49%11.4M----47.25%4.68M----
Total operating cost -7.57%275.47M1.23%153.63M-0.43%574.86M6.79%427.39M3.99%298.02M1.09%151.77M1.56%577.34M-1.03%400.22M4.55%286.59M8.57%150.14M
Operating cost -1.14%65.94M11.17%37.74M4.89%135.53M23.61%94.46M27.10%66.7M14.69%33.95M2.24%129.21M-7.96%76.42M-4.69%52.48M5.25%29.6M
Operating tax surcharges 23.33%4.31M53.66%3.16M24.03%8.91M13.67%5.2M-1.67%3.5M23.52%2.06M-8.06%7.18M-20.74%4.57M-15.10%3.56M-23.58%1.66M
Operating expense -5.44%156.09M2.40%90.88M-0.81%316.79M-2.46%230.67M-4.29%165.07M-6.76%88.75M-0.12%319.37M-0.30%236.48M8.16%172.47M14.85%95.19M
Administration expense -1.03%41.78M5.10%21.06M1.39%86.99M18.60%68.02M18.21%42.21M14.36%20.04M10.81%85.8M1.99%57.36M-1.73%35.71M-6.42%17.52M
Financial expense -163.13%-15.81M-138.66%-10.64M-91.24%-23.04M13.90%-10.81M-31.83%-6.01M4.18%-4.46M12.13%-12.05M2.98%-12.55M-73.41%-4.56M-116.52%-4.65M
-Interest expense (Financial expense) -57.50%7.94M-50.28%4.69M89.62%24.7M262.17%26.18M377.57%18.67M398.90%9.44M28.10%13.03M-13.37%7.23M-38.24%3.91M-46.07%1.89M
-Interest Income (Financial expense) 3.73%-23.91M-27.75%-17.89M-88.97%-48.09M-85.49%-37.23M-188.05%-24.83M-111.06%-14M-5.31%-25.45M6.64%-20.07M5.33%-8.62M-15.45%-6.63M
Research and development -12.79%23.17M-0.03%11.43M3.89%49.68M5.03%39.85M-1.38%26.56M5.67%11.43M-5.90%47.82M8.08%37.94M24.16%26.93M26.77%10.82M
Credit Impairment Loss -137.20%-509.76K-343.48%-3.12M159.92%1.13M-46.23%576.16K3.15%1.37M576.52%1.28M-78.54%-1.88M98.71%1.07M7.19%1.33M-340.71%-268.52K
Adjustment items of total operating cost -------0.01--------------------------------
Other net revenue 59.02%23.49M56.73%9.42M55.22%45.24M-6.63%22.65M-25.88%14.77M6.78%6.01M242.75%29.15M59.02%24.26M53.15%19.93M2.29%5.63M
Fair value change income --------121.54%271.43K121.54%271.43K121.54%271.43K----89.78%-1.26M---1.26M---1.26M----
Invest income -26.67%2.47M-84.91%90.9K-18.92%3.68M-10.44%3.42M-5.56%3.37M-33.29%602.25K-33.58%4.54M-10.56%3.82M-11.21%3.57M234.50%902.85K
-Including: Investment income associates -311.60%-130.43K164.42%90.9K245.95%375.71K142.43%117.75K131.56%61.64K-227.55%-141.09K74.62%-257.43K54.73%-277.49K50.12%-195.31K139.11%110.62K
Asset deal income 726,271.92%8.6M--5.68M138.26%172.51K-108.95%-1.18K-108.95%-1.18K----110.36%72.4K-62.70%13.23K-64.86%13.23K--13.23K
Other revenue 32.44%12.93M63.95%6.77M44.49%39.99M-10.83%18.38M-40.03%9.77M-17.11%4.13M84.30%27.67M98.06%20.61M110.88%16.29M-2.73%4.98M
Operating profit 14.01%100.61M26.98%76.7M-9.31%254.72M4.71%137.9M6.48%88.24M2.01%60.4M35.59%280.88M45.34%131.69M46.95%82.87M43.20%59.21M
Add:Non operating Income -85.59%360.85K-90.14%244.42K507.13%2.6M573.27%2.52M6,858.44%2.5M20,937.07%2.48M225.29%428.21K284.92%374.15K-54.49%35.98K-57.48%11.79K
Less:Non operating expense -66.78%130.22K-63.74%67.25K-27.83%2.41M-48.06%744.62K88.00%391.96K503.22%185.45K-46.32%3.34M-56.00%1.43M-88.84%208.49K-85.01%30.74K
Total profit 11.60%100.84M22.61%76.87M-8.29%254.91M6.92%139.67M9.25%90.35M5.92%62.7M38.25%277.97M49.38%130.63M51.44%82.7M43.77%59.19M
Less:Income tax cost -131.47%-37.06K-402.30%-256.56K-4.79%430.87K-36.78%308.73K-77.44%117.76K65.55%84.87K-39.60%452.57K-37.52%488.31K234.94%521.98K183.06%51.26K
Net profit 11.79%100.87M23.19%77.13M-8.30%254.48M7.09%139.36M9.80%90.24M5.86%62.61M38.54%277.51M50.16%130.14M49.43%82.18M43.43%59.14M
Net profit from continuing operation 11.79%100.87M23.19%77.13M-8.30%254.48M7.09%139.36M9.80%90.24M5.86%62.61M38.54%277.51M50.16%130.14M49.43%82.18M43.43%59.14M
Less:Minority Profit ------------------------47.58%-270.07K100.98%3.78K--162.71K--148.14K
Net profit of parent company owners 11.79%100.87M23.19%77.13M-8.39%254.48M7.09%139.36M10.02%90.24M6.13%62.61M38.32%277.78M49.49%130.14M49.13%82.02M43.07%58.99M
Earning per share
Basic earning per share 10.87%0.5121.88%0.39-9.09%1.35.97%0.719.52%0.466.67%0.3236.19%1.4348.89%0.6744.83%0.427.14%0.3
Diluted earning per share 10.87%0.5121.88%0.39-9.09%1.35.97%0.719.52%0.466.67%0.3236.19%1.4348.89%0.6744.83%0.427.14%0.3
Other composite income 133.22%12.9M87.02%10.7M247.16%2.99M270.86%5.39M19.38%5.53M17.39%5.72M-4.33%-2.03M-1,720.91%-3.15M42.31%4.63M-45.39%4.88M
Other composite income of parent company owners 133.22%12.9M87.02%10.7M247.16%2.99M270.86%5.39M19.38%5.53M17.39%5.72M-4.33%-2.03M-1,720.91%-3.15M42.31%4.63M-45.39%4.88M
Total composite income 18.80%113.78M28.54%87.83M-6.54%257.47M13.99%144.75M10.32%95.77M6.74%68.33M38.88%275.48M46.19%126.99M49.03%86.81M27.62%64.02M
Total composite income of parent company owners 18.80%113.78M28.54%87.83M-6.63%257.47M13.99%144.75M10.52%95.77M6.99%68.33M38.65%275.75M45.54%126.98M48.75%86.65M27.33%63.87M
Total composite income of minority owners ------------------------47.58%-270.07K100.98%3.78K--162.71K--148.14K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg